Last updated on November 2018

A Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 Infection


Brief description of study

This is a Phase 3b, open-label, multicenter study to evaluate the efficacy and safety of Glecaprevir (GLE)/Pibrentasvir (PIB) combination for an 8 or 12-week treatment duration in adults in Brazil with chronic hepatitis C virus (HCV) genotype (GT) 1 - 6 infection, without cirrhosis or with compensated cirrhosis, who are HCV treatment nave.

Clinical Study Identifier: NCT03219216

Contact Investigators or Research Sites near you

Start Over

ABBVIE CALL CENTER

Hospital Universit rio Cassiano Ant nio Moraes - HCUFES /ID# 163512
Vitoria, Brazil

ABBVIE CALL CENTER

Hospital de Clinicas de Porto Alegre /ID# 163166
Porto Alegre, Brazil

ABBVIE CALL CENTER

Hospital de Clinicas de Porto Alegre /ID# 163167
Porto Alegre, Brazil

ABBVIE CALL CENTER

Hospital Ernesto Dornelles /ID# 163171
Porto Alegre, Brazil

ABBVIE CALL CENTER

Unidade de Pesquisa Cl nica da Faculdade de Medicina de Botucatu /ID# 163066
Botucatu, Brazil

ABBVIE CALL CENTER

Instituto de Infectologia Campinas /ID# 163175
Campinas, Brazil

ABBVIE CALL CENTER

UNIFESP/Unidade de Atendimento Pesquisa Cl nica 1 /ID# 164188
Sao Paulo, Brazil

ABBVIE CALL CENTER

Centro de Refer ncia e Treinamento DST/AIDS /ID# 163174
Sao Paulo, Brazil

ABBVIE CALL CENTER

Hospital Heliopolis /ID# 163063
Sao Paulo, Brazil

ABBVIE CALL CENTER

Hospital Universitario da Universidade Federal do Maranhao - CEPEC /ID# 163169
São Luís, Brazil

ABBVIE CALL CENTER

Universidade Estadual de Maring /ID# 166436
Maringá, Brazil

ABBVIE CALL CENTER

Hospital das Clinicas da Faculdade de Medicina de Ribeir o Preto - USP /ID# 163054
Ribeirão Preto, Brazil

ABBVIE CALL CENTER

Instituto de Infectologia Emilio Ribas /ID# 163170
São Paulo, Brazil

ABBVIE CALL CENTER

Hospital das Cl nicas da Faculdade de Medicina da Universidade de S o Paulo - HC /ID# 163168
São Paulo, Brazil

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.